LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s stock price fell 19.2% during trading on Friday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares traded hands during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Down 19.2 %
The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The business’s fifty day moving average price is C$0.11 and its two-hundred day moving average price is C$0.11. The stock has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Recommended Stories
- Five stocks we like better than LexaGene
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Financial Services Stocks Investing
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
